Finance

Lists
002872:SHE
Tiansheng Pharmaceutical Group Co Ltd
5,59 CN¥
0,00%
(0,00) 1D
16 қаз., 15:01:15 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002872...
Open
5,63 CN¥
High
5,71 CN¥
Low
5,58 CN¥
Mkt. cap
1,85 млрд
Avg. vol.
4,40 млн
Volume
2,80 млн
52-wk high
6,28 CN¥
52-wk low
4,32 CN¥
EPS
-0,13 CN¥
Shares outstanding
318,00 млн
No. of employees
1 мың
Open
5,63 CN¥
High
5,71 CN¥
Low
5,58 CN¥
Mkt. cap
1,85 млрд
Avg. vol.
4,40 млн
Volume
2,80 млн
52-wk high
6,28 CN¥
52-wk low
4,32 CN¥
EPS
-0,13 CN¥
Shares outstanding
318,00 млн
No. of employees
1 мың
News stories
From web sources and news partners
About Tiansheng Pharmaceutical Group Co Ltd
CEO-
Employees1,27 мың
Founded2001 ж. 16 қаз.
Headquarters-
SectorPharmaceutical industry
Websitetszy.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
116,62 млн
165,28 млн
131,96 млн
101,03 млн
Cost of goods sold
53,08 млн
93,87 млн
68,75 млн
61,43 млн
Cost of revenue
53,08 млн
93,87 млн
68,75 млн
61,43 млн
Research and development expenses
4,57 млн
5,47 млн
5,56 млн
4,55 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,19 млн
68,62 млн
71,11 млн
58,74 млн
Operating expense
59,42 млн
89,12 млн
72,84 млн
60,01 млн
Total operating expenses
112,50 млн
182,99 млн
141,59 млн
121,43 млн
Operating income
4,12 млн
-17,71 млн
-9,63 млн
-20,40 млн
Other non operating income
-4,81 млн
-13,87 млн
-183,05 м.
5,81 млн
EBT including unusual items
-8,45 млн
-14,77 млн
-9,10 млн
-14,41 млн
EBT excluding unusual items
-1,62 млн
-25,01 млн
-10,56 млн
-13,64 млн
Income tax expense
405,91 м.
-4,52 млн
732,79 м.
393,26 м.
Effective tax rate
-4,80%
30,64%
-8,05%
-2,73%
Other operating expenses
-4,11 млн
9,54 млн
278,52 м.
4,25 млн
Net income
-8,63 млн
-10,08 млн
-9,78 млн
-14,39 млн
Net profit margin
-7,40%
-6,10%
-7,41%
-14,24%
Earnings per share
-
-
-
-
Interest and investment income
3,11 млн
6,57 млн
2,88 млн
4,40 млн
Interest expense
-4,03 млн
-
-3,63 млн
-3,45 млн
Net interest expenses
-918,81 м.
6,57 млн
-751,40 м.
948,40 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
30,53 млн
12,13 млн
20,21 млн
6,29 млн
Gain or loss from assets sale
-82,50 мың
164,58 м.
-
-1,01 млн
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары